1. Home
  2. NXPL vs LSTA Comparison

NXPL vs LSTA Comparison

Compare NXPL & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NextPlat Corp

NXPL

NextPlat Corp

HOLD

Current Price

$0.55

Market Cap

15.6M

ML Signal

HOLD

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

HOLD

Current Price

$1.87

Market Cap

16.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NXPL
LSTA
Founded
1997
1980
Country
United States
United States
Employees
N/A
26
Industry
Telecommunications Equipment
Misc Health and Biotechnology Services
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.6M
16.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NXPL
LSTA
Price
$0.55
$1.87
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$23.50
AVG Volume (30 Days)
188.1K
28.0K
Earning Date
11-13-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$57,151,000.00
$1,070,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.43
$1.81
52 Week High
$2.30
$4.20

Technical Indicators

Market Signals
Indicator
NXPL
LSTA
Relative Strength Index (RSI) 44.18 36.32
Support Level $0.53 $1.84
Resistance Level $0.59 $2.02
Average True Range (ATR) 0.06 0.11
MACD -0.00 -0.01
Stochastic Oscillator 27.81 19.44

Price Performance

Historical Comparison
NXPL
LSTA

About NXPL NextPlat Corp

NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: